doi: 10.1176/appi.neuropsych.16110310.
Epub 2017 May 3.
Preliminary Evidence on Cannabis Effectiveness and Tolerability for Adults With Tourette Syndrome
Affiliations
- PMID: 28464701
- DOI: 10.1176/appi.neuropsych.16110310
Item in Clipboard
Preliminary Evidence on Cannabis Effectiveness and Tolerability for Adults With Tourette Syndrome
J Neuropsychiatry Clin Neurosci.
2017 Fall.
Abstract
The authors retrospectively evaluated effectiveness and tolerability of cannabis in 19 adults with Tourette syndrome. Tics scores decreased by 60%, and 18 of the 19 participants were at least "much improved." Cannabis was generally well tolerated, although most participants reported side effects.
Keywords: Basal Ganglia Disorders; Drug/Psychotherapy Treatment of Neuropsychiatric Disorders; Neuropharmacology; Outcome Studies Biological/Pharmacological.
Similar articles
-
The Potential of Cannabinoid-Based Treatments in Tourette Syndrome.CNS Drugs. 2019 May;33(5):417-430. doi: 10.1007/s40263-019-00627-1. CNS Drugs. 2019. PMID: 30977108 Review.
-
Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients.Int J Mol Sci. 2017 Aug 10;18(8):1739. doi: 10.3390/ijms18081739. Int J Mol Sci. 2017. PMID: 28796166 Free PMC article.
-
Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.J Child Adolesc Psychopharmacol. 2010 Aug;20(4):291-8. doi: 10.1089/cap.2009.0125. J Child Adolesc Psychopharmacol. 2010. PMID: 20807067
-
Licensed Medical Cannabis Use in Gilles de la Tourette Syndrome: A Retrospective Long-term Follow-Up.Cannabis Cannabinoid Res. 2024 Jun;9(3):e878-e885. doi: 10.1089/can.2022.0281. Epub 2023 May 12. Cannabis Cannabinoid Res. 2024. PMID: 37172308
-
[Tics and Gilles de la Tourette syndrome].Rev Neurol. 2009 Jan 23;48 Suppl 1:S17-20. Rev Neurol. 2009. PMID: 19222010 Review. Spanish.
Cited by
-
The Potential of Cannabinoid-Based Treatments in Tourette Syndrome.CNS Drugs. 2019 May;33(5):417-430. doi: 10.1007/s40263-019-00627-1. CNS Drugs. 2019. PMID: 30977108 Review.
-
Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey.Cannabis Cannabinoid Res. 2019 Dec 9;4(4):265-274. doi: 10.1089/can.2018.0050. eCollection 2019. Cannabis Cannabinoid Res. 2019. PMID: 31872061 Free PMC article.
-
Vaporized Cannabis Is Effective and Well-Tolerated in an Adolescent with Tourette Syndrome.Med Cannabis Cannabinoids. 2019 Jan 25;2(1):60-63. doi: 10.1159/000496355. eCollection 2019 Sep. Med Cannabis Cannabinoids. 2019. PMID: 34676335 Free PMC article.
-
Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.Neurology. 2019 May 7;92(19):896-906. doi: 10.1212/WNL.0000000000007466. Neurology. 2019. PMID: 31061208 Free PMC article. Review.
-
Refractory Gilles de la Tourette Syndrome-Many Pieces That Define the Puzzle.Front Neurol. 2020 Dec 18;11:589511. doi: 10.3389/fneur.2020.589511. eCollection 2020. Front Neurol. 2020. PMID: 33391155 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
